Skip to main content
. 2022 Jan 27;12:1473. doi: 10.1038/s41598-022-05176-0

Figure 1.

Figure 1

Immunohistochemical staining of ALDH1A1, CD133, and mutant p53 of samples from lung adenocarcinoma patients. ALDH1A1 staining intensity was rated as weak (1+), moderate (2+), or strong (3+) and multiplied by the percentage of positive cells. ALDH1A1 score = (% of cells of intensity 1 × 1) + (% of cells of intensity 2 × 2) + (% of cells of intensity 3 × 3). The total scores were categorized as follows: 0–100 = grade 1; 101–200 = grade 2; and 201–300 = grade 3. Grade 2 or 3 tumors were considered positive for ALDH1A1. (A) ALDH1A1 score = 0 (intensity 0 × 0% positive cells). (B) ALDH1A1 score = 220 (intensity 1 × 20% positive cells + intensity 2 × 30% positive cells + intensity 3 × 50% positive cells). The percentage of CD133- and mutant p53-positive cells was graded as 0%–100%. CD133 positivity was defined as staining of more than 20% of the tumor cells (negative: ≤ 20%; positive: > 20%). (C) CD133-positive cells were 0%, negative. (D) CD133-positive cells were 100%, positive. (E) Mutant p53-positive cells were 0%, negative. (F) Mutant p53-positive cells were 100%, positive.